MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 207 filers reported holding MEDIVATION INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $16,821,000 | -26.3% | 278,952 | -43.8% | 0.01% | -33.3% |
| Q1 2016 | $22,836,000 | +28.6% | 496,637 | +35.2% | 0.01% | +50.0% |
| Q4 2015 | $17,751,000 | -4.5% | 367,218 | -16.0% | 0.01% | -14.3% |
| Q3 2015 | $18,583,000 | -21.7% | 437,257 | +110.4% | 0.01% | -12.5% |
| Q2 2015 | $23,734,000 | -17.7% | 207,820 | -7.0% | 0.01% | -27.3% |
| Q1 2015 | $28,834,000 | +81.8% | 223,394 | +40.3% | 0.01% | +83.3% |
| Q4 2014 | $15,861,000 | -32.1% | 159,233 | -32.6% | 0.01% | -33.3% |
| Q3 2014 | $23,353,000 | +168.9% | 236,206 | +109.7% | 0.01% | +200.0% |
| Q2 2014 | $8,684,000 | +456.0% | 112,653 | +364.3% | 0.00% | +200.0% |
| Q1 2014 | $1,562,000 | -68.0% | 24,263 | -68.3% | 0.00% | -50.0% |
| Q4 2013 | $4,885,000 | -35.0% | 76,544 | -38.9% | 0.00% | -50.0% |
| Q3 2013 | $7,511,000 | +138.5% | 125,309 | +95.8% | 0.00% | +100.0% |
| Q2 2013 | $3,149,000 | – | 64,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |